Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:670-672
Published online before print February 3, 2005, doi: 10.1161/01.STR.0000155732.27333.3c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/3/670    most recent
01.STR.0000155732.27333.3cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagotani, S.
Right arrow Articles by Abe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagotani, S.
Right arrow Articles by Abe, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATORVASTATIN
*HEPTANOIC ACID
*L-LYSINE
*PYRROLE
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Animal models of human disease
Right arrow Neuroprotectors

(Stroke. 2005;36:670.)
© 2005 American Heart Association, Inc.


Original Contributions

Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress

Shoko Nagotani, MD; Takeshi Hayashi, MD, PhD; Keiko Sato, MD, PhD; Wenri Zhang, MD, PhD; Kentaro Deguchi, MD; Isao Nagano, MD, PhD; Mikio Shoji, MD, PhD Koji Abe, MD, PhD

From the Department of Neurology, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan.

Correspondence to Dr Koji Abe, Department of Neurology, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama, Okayama, 700-8558, Japan. E-mail shokon{at}cc.okayama-u.ac.jp

Background and Purpose— This study aimed to clarify the effect of statins on spontaneous stroke and to examine the antioxidative effect in artificial transient middle cerebral artery occlusion (tMCAO).

Methods— Stroke-prone spontaneous hypertensive rats (SHR-SP) were treated with pitavastatin, atorvastatin, simvastatin, or vehicle for 4 weeks. Physiological parameters, serum lipids, and infarct volumes were examined. The markers for oxidative stresses on lipids and DNA were immunohistochemically detected in vehicle-treated or simvastatin-treated SHR-SP with tMCAO.

Results— Atorvastatin and simvastatin decreased infarct volumes, with simvastatin most effective. Simvastatin significantly reduced immunoreactivities for oxidative stress markers for lipids and DNA in neurons after tMCAO.

Conclusions— The results suggest that the antioxidative properties of statins may be implicated in their beneficial effects against neuronal damage in cerebral ischemia.


Key Words: cerebral infarction • HMG-CoA reductase inhibitors • oxidative stress • rats, inbred SHR




This article has been cited by other articles:


Home page
BrainHome page
J. Wang and S. Dore
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Brain, June 1, 2007; 130(6): 1643 - 1652.
[Abstract] [Full Text] [PDF]